Ferring Considers Global Restructuring, Up to 500 Jobs at Risk
Pharmaceutical giant Ferring is contemplating a significant restructuring, with potential job cuts affecting up to 500 employees worldwide. The company, which employs over 7,500 people across 50 countries, has begun informing staff at potentially affected sites about proposals that could lead to redundancies.
Ferring, headquartered in Switzerland, has not specified any particular countries that may be impacted by the planned changes. The company is considering a reduction of up to 500 jobs globally, which represents around 6.7% of its total workforce. Alongside potential job cuts, some positions may be relocated geographically to optimize business operations.
The implementation of these changes is subject to local consultations, ensuring that Ferring adheres to regional employment laws and regulations. The company aims to complete this process by the end of 2023.
Ferring's proposed restructuring could result in up to 500 job losses worldwide, with some positions potentially being relocated. The company has begun informing affected employees and will proceed with local consultations before finalizing any changes by the end of 2023.
